1-3 of 3
Ingrid Bolomska
Close
Sort by
Journal Articles

Treatment of Diffuse Large B-Cell Lymphoma with Rituximab, Intensive Induction and High-Dose Consolidation: The Final Analysis of the Czech Lymphoma Study Group (CLSG) R-MegaCHOP-ESHAP-BEAM (R-MEB) Trial.

Marek Trneny, Robert Pytlik, David Belada, Katerina Kubackova, Ingrid Vasova, Alice Sykorova, Tomas Kozak, Jan Pirnos, Milan Matuska, Ingrid Bolomska, Jana Pribylova, Marie Trnkova, Michaela Hamouzova, Pavel Klener
Journal: Blood
Blood (2007) 110 (11): 21.
https://doi.org/10.1182/blood.V110.11.21.21
Published: 2007
Journal Articles

Intensive Induction Is Beneficial for High Risk Younger Patients with Aggressive B-Cell Lymphoma, While Frontline ASCT Brings No Benefit: Final Analysis of MegaCHOP-BEAM and MegaCHOP-ESHAP-BEAM Studies.

Robert Pytlik, David Belada, Katerina Kubackova, Tomas Kozak, PhD, Milada Jankovska, Jan Pirnos, Ingrid Bolomska, Ingrid Vasova, Tomas Papajik, Alena Sykorova, Hana Siffnerova, Michaela Hamouzova, Pavel Klener, Marek Trneny
Journal: Blood
Blood (2006) 108 (11): 4692.
https://doi.org/10.1182/blood.V108.11.4692.4692
Published: 2006
Journal Articles

Rituximab Combination with Anthracyclin Based Chemothrapy Significantly Improved the Outcome of Young Patients with Diffuse Large B-Cell Lymphoma in Low as Well in High Risk Subgroups.

Marek Trneny, MD, David Belada, MD, Ingrid Vasova, MD, Robert Pytlik, MD, Tomas Kozak, MD, Alice Sykorova, MD, Katerina Kubackova, MD, Jan Pirnos, MD, Ingrid Bolomska, MD, Marketa Petrova, Ing
Journal: Blood
Blood (2005) 106 (11): 2444.
https://doi.org/10.1182/blood.V106.11.2444.2444
Published: 2005